JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.

DISEASES OF THE COLON & RECTUM, published by Lippincott Williams & Wilkins, stands as a critical resource in the field of gastroenterology, focusing on the comprehensive study and management of colorectal diseases. With an ISSN of 0012-3706 and an E-ISSN of 1530-0358, this journal serves a diverse audience, including researchers, clinicians, and students interested in the latest advancements in this vital area of medicine. Recognized for its quality, it holds a Q2 ranking in both Gastroenterology and Miscellaneous Medicine categories for 2023 and is positioned at the 58th percentile within its Scopus rank. Since its inception in 1958, the journal has dedicated itself to disseminating original research, reviews, and clinical studies, providing a platform for sharing innovative findings that drive the field forward. While it is not an open access journal, its content remains pivotal for professionals looking to stay apprised of evidence-based practices and emerging trends in colorectal health. With ongoing contributions expected until 2024, DISEASES OF THE COLON & RECTUM continues to be an indispensable source of knowledge for anyone engaged in the intricacies of digestive health.

Annals of Hepato-Biliary-Pancreatic Surgery is a leading academic journal dedicated to the fields of hepatobiliary and pancreatic surgery, contributing essential research and clinical insights to enhance surgical practices and patient outcomes. Published by the Korean Association of Hepato-Biliary-Pancreatic Surgery (KAHBPS), this journal serves as a vital resource for researchers, clinicians, and healthcare professionals interested in the latest advancements and methodologies within this specialized area. With an ISSN of 2508-5778 and an E-ISSN of 2508-5859, the journal presents a platform for high-quality, peer-reviewed articles that focus on the management and surgical techniques for liver, biliary, and pancreatic disorders. Although it currently offers limited open access options, the journal has been recognized in the 2023 Scopus Ranks, reflecting its influence in the medical community, particularly with a Q3 designation in Gastroenterology and Surgery. By fostering academic dialogue, the Annals of Hepato-Biliary-Pancreatic Surgery plays a crucial role in shaping evidence-based practice, making it indispensable for those engaged in this dynamic and evolving field.

DIGESTIVE DISEASES AND SCIENCES, a renowned journal published by Springer, plays a pivotal role in advancing the fields of gastroenterology and physiology. With a rich publication history spanning from 1979 to 2024, this journal not only holds an impressive Q1 ranking in both categories but also ranks 34th out of 167 in Gastroenterology and 60th out of 193 in Physiology according to Scopus, reflecting its significant impact and reputation within the academic community. Despite being a traditional journal without open access options, it remains a crucial platform for researchers, professionals, and students seeking to disseminate their findings and stay abreast of the latest developments in digestive health. The journal is accessible to a global audience and is dedicated to publishing high-quality, peer-reviewed research, making it an invaluable resource for anyone involved in the study or treatment of digestive diseases.

Gastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.

Surgical Oncology Clinics of North America, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of surgical oncology and surgery, captivating readers since its inception in 1995. With ISSN 1055-3207 and E-ISSN 1558-5042, this esteemed journal offers a comprehensive platform for the dissemination of cutting-edge research, clinical studies, and expert reviews pertaining to surgical techniques and oncological advancements. The journal currently holds a commendable Q3 ranking in Oncology and a Q2 ranking in Surgery, underpinned by its impressive Scopus rankings that place it in the top 25% of its category in Medicine, particularly in the surgical domain (Rank #137/551). Although it does not operate under an open-access model, the insights shared within its pages are invaluable for researchers, healthcare professionals, and students dedicated to enhancing patient outcomes in surgical oncology. With a commitment to advancing medical knowledge, Surgical Oncology Clinics of North America remains a crucial resource for those pursuing excellence in surgical practices and oncology treatment methodologies.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, published by Mosby-Elsevier, stands as a leading peer-reviewed journal dedicated to advancing the fields of thoracic and cardiovascular surgery. With an impressive impact factor reflecting its rigorous standards and significance, this journal occupies prestigious Q1 quartiles in 2023 across Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, as well as Surgery. Additionally, it boasts remarkable rankings in the Scopus database, being placed at #8 in Surgery and #29 in Cardiology and Cardiovascular Medicine, underscoring its pivotal role in disseminating high-quality research and clinical insights. Its scope encompasses vital areas such as surgical techniques, innovative therapies, and patient outcomes, making it an essential resource for researchers, clinicians, and students passionate about advancing cardiac and pulmonary health. Though not an open-access journal, it ensures that subscribers and institutional partners can access valuable research contributions published within its pages from 1959 to 2024. The JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY continues to shape the future of surgical practices and enhance patient care on a global scale.

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

Hepatobiliary & Pancreatic Diseases International, an esteemed journal published by Elsevier, stands as a vital resource within the field of gastroenterology and hepatology. Established in 2002, this journal has developed a significant reputation, currently ranked in the second quartile (Q2) in both categories as of 2023, showcasing its commitment to high-quality research and clinical studies. Based in Singapore, Hepatobiliary & Pancreatic Diseases International serves as an essential platform for researchers, clinicians, and healthcare professionals to share innovative findings, therapeutic approaches, and advancements in the understanding of hepatobiliary and pancreatic diseases. Although the journal does not currently offer Open Access, its rigorous peer-review process ensures that published articles maintain the highest scientific standards, fostering knowledge dissemination among the global research community. With a convergence period extending to 2024, this journal continues to play a pivotal role in enhancing the understanding and treatment of complex gastrointestinal conditions, making it a must-read for anyone engaged in this dynamic field.

Esophagus is a prestigious journal published by SPRINGER JAPAN KK, dedicated to advancing the field of gastroenterology. With an ISSN of 1612-9059 and E-ISSN 1612-9067, this journal has been a significant resource for researchers and practitioners since its inception in 2003. Covering a comprehensive range of topics related to esophageal health, diseases, and treatment advancements, Esophagus has established itself in the academic community, boasting a notable impact factor and achieving a ranking of #60 out of 167 in the gastroenterology category, placing it in the 64th percentile. The journal currently holds a Q2 status for the year 2023, emphasizing its contribution to high-quality research in the field. Located in the heart of Tokyo, Japan, this journal aims to foster collaboration and innovation within the gastroenterological community, welcoming submission of original research articles, review papers, and case studies that can significantly impact patient care and clinical practices.